AIM
ABBV icon

AHL Investment Management’s AbbVie ABBV Stock Holding History

AHL Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.42M Sell
19,079
-2,324
-11% -$473K 3.02% 9
2025
Q2 		$3.97M Buy
21,403
+1
+0% +$186 2.65% 11
2025
Q1 		$4.48M Sell
21,402
-889
-4% -$173K 3.09% 11
2024
Q4 		$3.96M Buy
22,291
+91
+0.4% +$16.7K 2.77% 11
2024
Q3 		$4.38M Sell
22,200
-239
-1% -$44.6K 3.02% 11
2024
Q2 		$3.85M Buy
22,439
+1
+0% +$166 2.82% 11
2024
Q1 		$4.09M Sell
22,438
-518
-2% -$89.3K 3.13% 10
2023
Q4 		$3.56M Sell
22,956
-8
-0% -$1.17K 2.91% 12
2023
Q3 		$3.42M Sell
22,964
-49
-0.2% -$7.19K 3.05% 12
2023
Q2 		$3.1M Sell
23,013
-541
-2% -$79.3K 2.76% 13
2023
Q1 		$3.75M Sell
23,554
-584
-2% -$89.3K 3.46% 10
2022
Q4 		$3.9M Sell
24,138
-290
-1% -$44.5K 3.62% 8
2022
Q3 		$3.28M Sell
24,428
-34
-0.1% -$4.88K 3.37% 11
2022
Q2 		$3.75M Sell
24,462
-3,122
-11% -$477K 3.77% 9
2022
Q1 		$4.47M Sell
27,584
-864
-3% -$126K 4.1% 6
2021
Q4 		$3.85M Buy
+28,448
New +$3.36M 3.52% 6

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AHL Investment Management's ABBV Position: Q3 2025 in Review

AHL Investment Management reduced its AbbVie (ABBV) stake by 11% in Q3 2025, selling an estimated $473K and leaving 19,079 shares worth $4.42M. The position accounts for 3.02% of the portfolio, ranked #9.

AHL Investment Management first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. The position peaked at $4.48M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • AHL Investment Management held 19,079 shares of AbbVie worth $4.42M as of Q3 2025.
  • AHL Investment Management sold 2,324 AbbVie shares in Q3 2025, an estimated $473K.
  • AbbVie made up 3.02% of AHL Investment Management's portfolio in Q3 2025, its #9 holding.
  • AHL Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • AHL Investment Management's AbbVie position peaked at $4.48M in Q1 2025.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on AHL Investment Management's 13F filing for Q3 2025, filed 2 Oct 2025.